| scholarly article | Q13442814 |
| P50 | author | Caleb Banta-Green | Q80946624 |
| P2093 | author name string | Robin A Pollini | |
| Richard S Garfein | |||
| Jazmine Cuevas-Mota | |||
| Eyasu Teshale | |||
| Mitcheal Metzner | |||
| P2860 | cites work | Overdose among heroin users in Sydney, Australia: II. responses to overdose. | Q51000201 |
| The long-term outcome of a personal network-oriented HIV prevention intervention for injection drug users: the SAFE Study. | Q51569111 | ||
| Situational factors influencing drug injecting, risk reduction and syringe exchange in Togliatti City, Russian Federation: a qualitative study of micro risk environment | Q57773789 | ||
| The impact of a police drug crackdown on drug injectors' ability to practice harm reduction: a qualitative study | Q81756153 | ||
| Public injecting and HIV risk behaviour among street-involved youth. | Q34001228 | ||
| Transient changes in behaviour lead to heroin overdose: results from a case-crossover study of non-fatal overdose. | Q34413365 | ||
| The STEP into Action study: a peer-based, personal risk network-focused HIV prevention intervention with injection drug users in Baltimore, Maryland | Q34629993 | ||
| Initiation into prescription opioid misuse amongst young injection drug users | Q35388380 | ||
| Prescription opioid abuse and diversion in an urban community: the results of an ultrarapid assessment | Q37286475 | ||
| Injection drug users in the Midwest: an epidemiologic comparison of drug use patterns in four Ohio cities | Q39385536 | ||
| Safety becomes danger: dilemmas of drug-use in public space | Q39584331 | ||
| Circumstances of witnessed drug overdose in New York City: implications for intervention | Q39722651 | ||
| Illicit use of opioids: is OxyContin a "gateway drug"? | Q39803866 | ||
| Public injection settings in Vancouver: physical environment, social context and risk | Q40185034 | ||
| Geographical injecting locations among injecting drug users in Sydney, Australia | Q43341766 | ||
| HIV prevention among drug users: outcome of a network-oriented peer outreach intervention | Q44562867 | ||
| Response to overdose among injection drug users | Q45054109 | ||
| Witnessing heroin-related overdoses: the experiences of young injectors in San Francisco. | Q46050131 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P304 | page(s) | 173-180 | |
| P577 | publication date | 2011-10-01 | |
| P1433 | published in | Substance Abuse and Rehabilitation | Q15817526 |
| P1476 | title | Problematic use of prescription-type opioids prior to heroin use among young heroin injectors | |
| P478 | volume | 2 |
| Q52301622 | "Hooked on" prescription-type opiates prior to using heroin: results from a survey of syringe exchange clients. |
| Q36787556 | A Prospective Study to Investigate Predictors of Relapse among Patients with Opioid Use Disorder Treated with Methadone |
| Q51741856 | A fragmented code: The moral and structural context for providing assistance with injection drug use initiation in San Diego, USA. |
| Q44348351 | Adverse childhood experience effects on opioid use initiation, injection drug use, and overdose among persons with opioid use disorder |
| Q59808128 | An age-based analysis of nonmedical prescription opioid use among people who use illegal drugs in Vancouver, Canada |
| Q35882669 | Association between non-fatal opioid overdose and encounters with healthcare and criminal justice systems: Identifying opportunities for intervention |
| Q37455559 | Association between prescription drug misuse and injection among runaway and homeless youth |
| Q50062946 | Buprenorphine Treatment for Adolescents and Young Adults With Opioid Use Disorders: A Narrative Review. |
| Q37298826 | Characterizing and improving HIV and hepatitis knowledge among primary prescription opioid abusers |
| Q51847014 | Confronting the emerging epidemic of HCV infection among young injection drug users. |
| Q33836760 | DNA Methylation Profiling of Human Prefrontal Cortex Neurons in Heroin Users Shows Significant Difference between Genomic Contexts of Hyper- and Hypomethylation and a Younger Epigenetic Age. |
| Q38811829 | Down in the valley: Trajectories of injection initiation among young injectors in California's Central Valley |
| Q40464430 | Drug use generations and patterns of injection drug use: Birth cohort differences among people who inject drugs in Los Angeles and San Francisco, California. |
| Q36389066 | Dynamic model of nonmedical opioid use trajectories and potential policy interventions |
| Q33862919 | Ending hepatitis C in the United States: the role of screening. |
| Q85360197 | Engaging Law Enforcement in Overdose Reversal Initiatives: Authorization and Liability for Naloxone Administration |
| Q50113262 | Enhancing Efficacy and Stability of an Antiheroin Vaccine: Examination of Antinociception, Opioid Binding Profile, and Lethality |
| Q36744335 | Epidemiology of Injection Drug Use: New Trends and Prominent Issues |
| Q56521977 | Evolution and convergence of state laws governing controlled substance prescription monitoring programs, 1998-2011 |
| Q38020157 | Evolving epidemiology of hepatitis C virus in the United States |
| Q37308020 | Factors associated with being asked to initiate someone into injection drug use |
| Q34773972 | Factors associated with initiating someone into illicit drug injection. |
| Q36248819 | Gender and nonmedical prescription opioid use and DSM-5 nonmedical prescription opioid use disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions - III. |
| Q37129993 | Geographical and temporal variation of injection drug users in Pakistan |
| Q40480403 | Geospatial Analysis of Drug Poisoning Deaths Involving Heroin in the USA, 2000-2014. |
| Q93374969 | Heat shock proteins: A dual carrier-adjuvant for an anti-drug vaccine against heroin |
| Q28536725 | High prevalence of illicit drug use in men who have sex with men with HIV-1 infection in Japan |
| Q28535181 | Illicit drug use is a significant risk factor for loss to follow up in patients with HIV-1 infection at a large urban HIV clinic in Tokyo |
| Q92626659 | Increased frequency of urine drug testing in chronic opioid therapy: rationale for strategies for enhancing patient adherence and safety |
| Q34691743 | Individual and socio-environmental factors associated with unsafe injection practices among young adult injection drug users in San Diego |
| Q90631216 | Initiation into heroin use among street-involved youth in a Canadian setting: A longitudinal cohort study |
| Q39250810 | Initiation into prescription opioid injection and associated trends in heroin use among people who use illicit drugs |
| Q92721827 | Long-term tracking of opioid consumption in two United States cities using wastewater-based epidemiology approach |
| Q97537180 | Longitudinal trends in nonmedical prescription opioid use in a cohort of rural Appalachian people who use drugs |
| Q44330729 | Methadone versus buprenorphine for the treatment of opioid abuse in pregnancy: science and stigma |
| Q28005556 | National Trends in Hospitalizations for Opioid Poisonings Among Children and Adolescents, 1997 to 2012 |
| Q39660154 | Nonmedical Prescription Opioid Use and DSM-5 Nonmedical Prescription Opioid Use Disorder in the United States |
| Q36421383 | Nonmedical opioid use and heroin use in a nationally representative sample of us high school seniors |
| Q47729402 | Nonmedical prescription opioid use and illegal drug use: initiation trajectory and related risks among people who use illegal drugs in Vancouver, Canada |
| Q51826024 | Overdose Epidemic, Prescription Monitoring Programs, and Public Health: A Review of State Laws. |
| Q26747507 | Overlapping Mechanisms of Stress-Induced Relapse to Opioid Use Disorder and Chronic Pain: Clinical Implications |
| Q48148489 | Patient perspectives of transitioning from prescription opioids to heroin and the role of route of administration. |
| Q36619410 | Predictors of transition to heroin use among initially non-opioid dependent illicit pharmaceutical opioid users: A natural history study |
| Q99552613 | Prescription Opioid Dispensing Patterns Prior to Heroin Overdose in a State Medicaid Program: a Case-Control Study |
| Q34674284 | Prescription opioid misuse and mental health among young injection drug users. |
| Q64069420 | Rising role of prescription drugs as a portal to injection drug use and associated mortality in Baltimore, Maryland |
| Q51816433 | Risk factors for HCV infection among young adults in rural New York who inject prescription opioid analgesics. |
| Q39173763 | Striatal H3K27 Acetylation Linked to Glutamatergic Gene Dysregulation in Human Heroin Abusers Holds Promise as Therapeutic Target. |
| Q52665558 | The Epidemic of Neonatal Abstinence Syndrome, Historical References of Its' Origins, Assessment, and Management. |
| Q92055174 | The Opioid Crisis: The Surgeon's Role |
| Q40802348 | The Pain Reliever and Heroin Epidemic in the United States: Shifting Winds in the Perfect Storm |
| Q38533533 | The epidemic of prescription opioid abuse, the subsequent rising prevalence of heroin use, and the federal response |
| Q38666883 | The experience of initiating injection drug use and its social context: A qualitative systematic review and thematic synthesis |
| Q38640212 | The risk for problematic opioid use in chronic pain: What can we learn from studies of pain and reward? |
| Q38376069 | Treatment utilization among persons with opioid use disorder in the United States. |
| Q42687510 | Type of opioids injected: does it matter? A multicentric cross-sectional study of people who inject drugs |
| Q57462909 | Understanding the Agent, Part III: Specific Drugs |
| Q36924019 | Understanding the etiology of prescription opioid abuse: implications for prevention and treatment |
Search more.